Detall de la convocatòria


Objectiu de la convocatòria
FRAXA is a nonprofit, tax-exempt organization based the US. Solely committed to finding a cure for fragile X, FRAXA has funded more than $25 million in biomedical research, yielding discoveries that are changing the lives of families coping with fragile X. FRAXA is one of the most efficient and effective charities in the world, with management and general expenses under 4 percent and research expenditures at 86 percent.
Característiques principals
These grants are strictly for clinical research with fragile X subjects. Strong emphasis will be placed on clinical trials of potentially disease-modifying agents which have been previously validated in fragile X animal models. Other types of clinical research may be considered, such as biomarker studies in fragile X patients, or trials of symptomatic therapies; however, these will be accorded lower priority in funding decisions.
No limit to structure of grant (can fund PI, postdoc, grad student, technician, supplies, etc.) or time-frame (though all grants over one year still need yearly renewal)
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
Carol Barnwell: Ext.: 1670
Marta López: Ext.: 1576
Convocatòria (URL)
No limit on amount, but please remember that applications are ranked based on relative value, so smaller requests have an advantage!
Applications may be submitted at any time, but a Letter of Intent (LOI) is essential; initial inquiries should be directed to Dr. Michael Tranfaglia at